Novel chimeric histone deacetylase inhibitors: a series of lapatinib hybrides as potent inhibitors of epidermal growth factor receptor (EGFR), human epidermal growth …

S Mahboobi, A Sellmer, M Winkler…

Index: Journal of Medicinal Chemistry, , vol. 53, # 24 p. 8546 - 8555

Full Text: HTML

Citation Number: 49

Abstract

... Journal of Medicinal Chemistry. ... Department of Pharmaceutical Chemistry I, University of Regensburg, D-93040 Regensburg, Germany. ‡ Nycomed GmbH, Therapeutic Area Oncology, Byk-Gulden Strasse 2, D-78467 Konstanz, Germany. ...

Related Articles:

Synthetic approaches to the 2011 new drugs

[EP1481971 A1, ; Page 8-9 ;]

Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series

[Bioorganic and Medicinal Chemistry Letters, , vol. 16, # 17 p. 4686 - 4691]

Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series

[Bioorganic and Medicinal Chemistry Letters, , vol. 16, # 17 p. 4686 - 4691]

Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series

[Bioorganic and Medicinal Chemistry Letters, , vol. 16, # 17 p. 4686 - 4691]

More Articles...